3-Hydroxy-3-methyl-2,4-nonanedione
Common Name: |
3-Hydroxy-3-methyl-2,4-nonanedione |
IUPAC Name: |
3-hydroxy-3-methylnonane-2,4-dione |
Molecular Formula: |
C15H24 |
SMILES: |
CCCCCC(=O)C(C)(C(=O)C)O |
Inchi: |
1S/C10H18O3/c1-4-5-6-7-9(12)10(3,13)8(2)11/h13H,4-7H2,1-3H3 |
Inchi Key: |
LWAGDIOTWITDPB-UHFFFAOYSA-N |
Cas No: |
544409-58-7 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
204.35 |
Mass (g/mol) |
186.126 |
Molar Refractivity |
70.42 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
3 |
Rings |
|
TPSA |
0.00 |
Hetero Atoms |
3 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
275.00 to 276.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.001 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
1.476 |
iLOGP |
3.43 |
XLOGP3 |
5.27 |
WLOGP |
4.75 |
MLOGP |
4.53 |
ESOL Log S |
-4.23 |
ESOL Solubility (mg/ml) |
0.012 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.02 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.55 |
Silicos-IT Solubility (mg/ml) |
0.06 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.80 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.858 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.848 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |